Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Arquivos Brasileiros De Oftalmologia|September 25, 2024
Guardians of the ocular surface: lessons learned from a challenging case of Langerhans cell histiocytosis with eyelid involvementLaura Goldfarb Cyrino, Andrea Santucci Cesar, Lia Zumblick, et al.European Journal of Internal Medicine|August 6, 2023
Catheter-based renal artery denervation: facts and expectationsPaolo Verdecchia, Claudio Cavallini, Rocco Sclafani, et al.Minerva Cardioangiologica|March 3, 2016
Radial versus femoral approach in STEMI: what do we know so far?Andrea Santucci, Giuseppe Gargiulo, Sara Ariotti, et al.Annals of Internal Medicine|June 13, 2017
Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary InterventionRaffaele Piccolo, Giuseppe Gargiulo, Anna Franzone, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 16, 2017
Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trialGiuseppe Gargiulo, Andrea Santucci, Raffaele Piccolo, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 14, 2019
Predictors of in-hospital and long-term mortality in unselected patients admitted to a modern coronary care unitAlfonso Campanile, Claudia Castellani, Andrea Santucci, et al.Diagnostics (Basel, Switzerland)|May 13, 2023
Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The 'Ambulatory Does Prediction Valid (ADPV)' ApproachFabio Angeli, Gianpaolo Reboldi, Francesco Giuseppe Solano, et al.Clinical Chemistry and Laboratory Medicine|October 29, 2021
Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary interventionFabio Angeli, Paolo Verdecchia, Stefano Savonitto, et al.JAMA Cardiology|August 31, 2016
Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical TrialAnna Franzone, Raffaele Piccolo, Giuseppe Gargiulo, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2017
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trialRaffaele Piccolo, Giulia Magnani, Sara Ariotti, et al.Pageof 3